BioSpace News Archive

Myonex, a leading global clinical trial supply company, announces the launch of the first and only on-demand local drug sourcing in Europe.

Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle nucleic acid delivery platform, and Centre National de Recherche et de Formation sur le Paludisme, the Burkina Faso site team lead by Dr. Gansane Adama, announced that enrollment is now complete into the single and two-dose cohorts of the Phase 2 clinical trial of Covigenix VAX-001-1b, its COVID-19 DNA vaccine.

Cure Rare Disease, a clinical-stage nonprofit biotechnology company, has acquired its first laboratory space at 4 Research Drive in Woodbridge, Connecticut, where the organization will relocate its headquarters and expand its research and development operations.

SpringWorks Therapeutics, Inc. announced that the first patient has been dosed in a Phase 2 trial evaluating nirogacestat, SpringWorks’ investigational gamma secretase inhibitor, as a monotherapy in patients with recurrent ovarian granulosa cell tumors.

Merck, known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, October 27.

Krystal Biotech, Inc. announced today that the Company will participate in the Chardan’s 6th Annual Genetic Medicines Conference in New York from October 3-4.

Societal CDMO, Inc. announced that it has signed multiple CDMO service agreements with both new and existing customers.

BD, a leading global medical technology company, in conjunction with Heart to Heart International, the National Association of Free and Charitable Clinics and Henry Schein Cares, announced that six U.S. free and charitable clinics will be awarded product-based grants worth a total of $360,000 to support point-of-care diagnostic testing in communities with underserved and at-risk patient populations.

Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, components and tubing, has introduced HelixFlex™, a high purity thermoplastic elastomer TPE tubing designed for use in biopharmaceutical fluid transfer applications.

Zynerba Pharmaceuticals, Inc. today announced that Stephen O’Quinn, Pharm.D., Vice President, Medical Affairs, Zynerba Pharmaceuticals, will participate in a panel discussion at the 2022 Cantor Neurology & Psychiatry Conference being held October 6-7, 2022 in San Francisco, Calif.